Serum MMP-8 is associated with adverse CSS in CRC, independent of tumour stage, grade, lymphatic invasion, BRAF VE1 immunohistochemistry, MMR deficiency, Immunoscore and mGPS. Here, MRC1 is linked to neoplasm.